Hoxworth urging blood donations amid coronavirus concerns

Officials at Hoxworth Blood Center, University of Cincinnati are appealing to the tristate community for blood donations in order to maintain a stable blood supply amid concerns about the recent coronavirus (COVID-19) outbreak.

“There is currently a critical shortage of blood products throughout the country,” says Alecia Lipton, spokesperson for Hoxworth Blood Center. “Hoxworth Blood Center has been contacted by blood banks in regions affected by the coronavirus outbreak for assistance in providing much needed blood products. We are appealing to the tristate community to donate blood to help patients not just in Cincinnati, but in other areas of the U.S. as well.”

Lipton notes that the states of Washington, California, Florida, New York, Maryland and Oregon have declared states of emergency due to COVID-19, and blood donations in these states have fallen drastically as a result.

Blood donors are being asked to make and keep scheduled blood donation appointments, as blood and platelets will still be needed by patients. According to Lipton, Hoxworth needs to collect at least 400 units of blood and 40 units of platelets every day just to meet the local demand by area hospitals.

Lipton says that Hoxworth Blood Center will implement additional safety measures beginning on Tuesday, March 10 out of an abundance of caution and to ensure that Hoxworth staff are not a source of transmission.

Blood center employees that are within one meter of contact with donors and visitors will be provided with face masks and gloves to wear. At donor centers and blood drives, gloves will be changed between donors during phlebotomy and screening.

Blood center officials continue to reassure the Cincinnati community that blood donation is a safe, sterile process and there is no risk of contracting the virus by donating blood.

“The coronavirus outbreak poses no additional risk to blood donors for the mere fact of being blood donors, either during the donation process or from attending organized blood drives,” says David Oh, MD, medical director of Hoxworth. “COVID-19 also poses no additional risk to patients receiving blood transfusions. The U.S. Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC) have not changed their recommendation that no additional action by blood centers is warranted at this time, and we remain in regular contact with both agencies regarding changes to donation eligibility and screening criteria.”

To be eligible for blood donation, donors must be at least 17 years old (16 with parental consent), feeling generally well and healthy, and have no active cold or flu symptoms.  To schedule a donation, call (513) 451-0910 or visit www.hoxworth.org.

About Hoxworth

Hoxworth Blood Center, University of Cincinnati was founded in 1938 and serves over 30 hospitals and medical facilities in Ohio, Kentucky and Indiana.  Hoxworth collects blood from local donors to help save the lives of patients in area hospitals. Hoxworth Blood Center.  All Types Welcome.

Related Stories

1

The subtle changes in hearing you should never ignore

July 24, 2026

It’s easy to dismiss changes in hearing as minor. But as The Washington Post recently reported, these symptoms could also signal a medical emergency that many people don’t recognize — known as sudden sensorineural hearing loss, a rapid decline in hearing that occurs suddenly or over a few days.

2

UC experts say proper produce washing is key defense against Cyclospora

July 24, 2026

Hamilton County Public Health reports confirmed cases of cyclosporiasis, as concerns persist. Cyclospora is a parasite that can cause a stomach illness lasting days — sometimes even weeks. University of Cincinnati medical experts say it is usually linked to contaminated water or food, often fresh produce.

3

What are the options for male birth control?

July 24, 2026

Despite major advances in contraception during the past several decades, responsibility for pregnancy prevention falls largely on women. As recently reported in Endocrinology Advisor, a new generation of male contraceptive candidates is advancing into early- and mid-stage clinical trials.